Eventide Asset Management »

Immix Biopharma shares owned by Eventide Asset Management

Quarter-by-quarter ownership of Immix Biopharma (IMMX) shares owned by Eventide Asset Management from 13F filings

Historical chart of Eventide Asset Management investment in Immix Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Immix Biopharma held by Eventide Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immix Biopharma by Eventide Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $13M 2.5M 5.23

More positions owned by Eventide Asset Management

Guardant Health (GH)
Xometry Class A Com (XMTR)
Mirum Pharmaceuticals (MIRM)
Trane Technologies SHS (TT)
Beta Bionics (BBNX)
Irhythm Technologies (IRTC)
Ge Vernova (GEV)
Lam Research Corp Com New (LRCX)
Scholar Rock Hldg Corp (SRRK)
Axsome Therapeutics (AXSM)
Argenx Se Sponsored Adr (ARGX)
Old Dominion Freight Line (ODFL)
Targa Res Corp (TRGP)
Toast Cl A (TOST)
Collegium Pharmaceutical Inc Common Stock Usd (COLL)

View all positions for Eventide Asset Management

Top funds holding Immix Biopharma

Saturn V Capital Management
Eventide Asset Management
Marshall Wace
Vanguard Group
Logos Global Management
Bleichroeder
Blue Owl Capital Holdings
Franklin Resources
Susquehanna International
Renaissance Technologies
Geode Capital Management
KVP Capital Advisors
Goldman Sachs Group
Jane Street
LGT Fund Management

View all funds holding Immix Biopharma